Navigation Links
Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Date:5/26/2008

WALTHAM, Mass., May 26 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming FBR Capital Markets 12th Annual Spring Investor Conference being held May 28, 2008 at the Grand Hyatt in New York. Ron Geraty, President, Health Management, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, May 28, 2008 at 9:45 a.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and through FBR's website at http://www.wsw.com/webcast/fbr21/ima/ . A replay of the webcast will be available via the links above for 90 days. During their presentation Mr. Geraty or Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

An investor presentation to be provided at the conference will be made available to the public on the company's website via the link provided above.

Inverness Medical Innovations is a leading global developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno- diagnostics with a focus on women's health, cardiology an
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
2. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
3. Inverness Medical Innovations Announces First Quarter 2008 Results
4. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
5. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
6. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
7. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
10. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
11. Inverness Medical Innovations Acquires ParadigmHealth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 According to the new ... Media, Pre-formulated Media), by Application (Biobanking, Regenerative Medicine, Drug Discovery), ... Europe , Asia-Pacific , Rest of ... biopreservation media market was valued at $247.7 million in 2014, ... 2019, at a CAGR of 18.2% between 2014 and 2019. ...
(Date:7/27/2015)... -- IDEXX Laboratories, Inc. (NASDAQ: IDXX ) announced ... 100,000 specimens to IDEXX Reference Laboratories for symmetric dimethylarginine, ... since the breakthrough kidney function test launched in the ... of suffering and death in cats and dogs. The ... accepted kidney disease prevalence data showing that 1 in ...
(Date:7/25/2015)... ... July 25, 2015 , ... Technology leader Anton ... checks and adjusts the surface temperature of the measuring prism. This is required ... data traceability and documentation are key requirements. It is likely that no refractometer ...
(Date:7/24/2015)... Equity Research Institute has initiated ... PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ... Inc. (NASDAQ: NWBO ), and Acorda Therapeutics Inc. ... BioPharma can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI On ... 5,146.41, down 0.49%, the Dow Jones Industrial Average declined ...
Breaking Biology Technology:Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5It’s T-Time for Refractometers: On-site Temperature Check Now Available 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... Incremental Data to be Presented at ASCO GI ... to Oxaliplatin in First-Line Colorectal Cancer Treatment -SOUTH ... Inc. (Nasdaq: PARD ), a biopharmaceutical ... updated efficacy and safety data from its randomized, ...
... a top question of Jatropha developers is, "What impact ... sector and its prominence as a viable, sustainable biofuel?" ... 20 January webinar has been scheduled. As a precursor ... lend crucial answers to hard-hitting inquiries by Jatropha investors. ...
... will be presented at Photonics West 2009PITTSFIELD, Mass., ... international society for optics and photonics, and Laurin ... 67 finalist companies for the 2008 Prism Awards ... photonics industry worldwide. The Prism Awards, introduced for ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 5Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights 2Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights 3Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights 4SPIE and Laurin Publishing Announce Prism Awards Finalists 2SPIE and Laurin Publishing Announce Prism Awards Finalists 3
(Date:7/9/2015)... 07, 2015 Research ... of the "Biometrics for Banking; Market & ... report to their offering. The adoption ... this growth and the forecast is that by ... for companies involved in delivering biometric systems to ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. (NASDAQ: ... diagnostics, today announced the launch of a study ... Precision Cancer Monitoring℠ (PCM) technology for predicting response ... or a combination of the novel immunotherapy agents ... a PD-1 inhibitor. The 50-patient study will be ...
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... A compound derived from cottonseed could help improve the ... researchers at the University of Michigan Comprehensive Cancer Center ... July issue of the journal Molecular Cancer Therapeutics, could ... to surgically removing the cancer, helping patients preserve vital ...
... water droplets to create adhesive bonds almost as strong as ... , The new beetle-inspired switch, designed by Cornell University engineers, ... -- a millionth of a meter. The switches can be ... Like the transistor, whose varied uses became apparent only following ...
... the National Institute of Allergy and Infectious Diseases (NIAID), ... the surprising discovery that flaviviruses, which cause such serious ... of encephalitis, evade immune system defenses in different ways ... ticks. This finding could lead to new approaches to ...
Cached Biology News:Compound from Chinese medicine shows promise in head and neck cancer 2Compound from Chinese medicine shows promise in head and neck cancer 3Beetle-inspired switch uses water for bonding 2Scientists show that tick-borne flaviviruses use a novel mechanism to evade host defenses 2Scientists show that tick-borne flaviviruses use a novel mechanism to evade host defenses 3
RABBIT ANTI HUMAN APP (KP1 DOMAIN) Immunogen: Synthetic peptide composed of amino acids 292-312 from the KPI domain of human APP....
Anti-Goat HRP-AEC Cell & Tissue Staining Kit...
... The CultureWell cell culture ... for preparing cultured cells for ... uses medical-grade silicone gaskets preassembled ... cell culture plates. The entire ...
... Zero Background/Kan Cloning Kit includes ... resistance for selection in E. ... positive selection to eliminate high ... of the reagents you need ...
Biology Products: